MedicaidAdministrativeMedium impact
Coordinated Prospective Drug Utilization Review
Maryland Medicaid·MD · Pharmacy·Pharmacy
Effective date
Jun 1, 1999
We identified it
Jun 20, 2026
Summary
Maryland Medicaid is implementing a Coordinated Prospective Drug Utilization Review system requiring pharmacies to use DEA numbers as prescriber identification for all Medicaid prescription claims. This replaces the previous prescriber identification system to enable comprehensive drug interaction checking across managed care and fee-for-service systems.
Action Required
By June 1, 1999: Pharmacies must submit DEA numbers in the Medicaid prescriber field for all prescription claims. Providers must respond promptly to Program letters requesting DEA number information. Use special codes (OH/OA for hospitals/clinics, NH for nursing homes, MD9999999 for unidentified prescribers without DEA numbers) only when individual prescriber DEA numbers are unavailable.